Expression of IL-23/Th17-related cytokines in basal cell carcinoma and in the response to medical treatments
Open Access
- 22 August 2017
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (8) , e0183415
Abstract
Several immune-related markers have been implicated in basal cell carcinoma (BCC) pathogenesis. The BCC inflammatory infiltrate is dominated by Th2 cytokines, suggesting a specific state of immunosuppression. In contrast, regressing BCC are characterized by a Th1 immune response with IFN-γ promoting a tumor suppressive activity. IL-23/Th17-related cytokines, as interleukin (IL)-17, IL-23 and IL-22, play a significant role in cutaneous inflammatory diseases, but their involvement in skin carcinogenesis is controversial and is poorly investigated in BCC. In this study we investigated the expression of IFN-γ, IL-17, IL-23 and IL-22 cytokines in BCC at the protein and mRNA level and their modulation during imiquimod (IMQ) treatment or photodynamic therapy (PDT). IFN-γ, IL-17, IL-23 and IL-22 levels were evaluated by immunohistochemistry and quantitative Real Time PCR in 41 histopathologically-proven BCCs (28 superficial and 13 nodular) from 39 patients. All BCC samples were analyzed at baseline and 19 of 41 also during medical treatment (9 with IMQ 5% cream and 10 with MAL-PDT). Association between cytokines expression and clinico-pathological variables was evaluated. Higher levels of IFN-γ, IL-17, IL-23 and IL-22 were found in BCCs, mainly in the peritumoral infiltrate, compared to normal skin, with the expression being correlated to the severity of the inflammatory infiltrate. IFN-γ production was higher in superficial BCCs compared to nodular BCCs, while IL-17 was increased in nodular BCCs. A significant correlation was found between IFN-γ and IL-17 expression with both cytokines expressed by CD4+ and CD8+ T-cells. An increase of all cytokines occurred during the inflammatory phase induced by IMQ and at the early time point of PDT treatment, with significant evidence for IFN-γ, IL-23, and IL-22. Our results confirm the role of IFN-γ and support the involvement of IL-23/Th17-related cytokines in BCC pathogenesis and in the inflammatory response during IMQ and MAL-PDT treatments.Keywords
This publication has 61 references indexed in Scilit:
- Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse modelJournal of Experimental Medicine, 2013
- Th17 Cells Are Long Lived and Retain a Stem Cell-like Molecular SignatureImmunity, 2011
- Smad4 deficiency in T cells leads to the Th17-associated development of premalignant gastroduodenal lesions in miceJournal of Clinical Investigation, 2011
- IL-17 Enhances Tumor Development in Carcinogen-Induced Skin CancerCancer Research, 2010
- Th17 Cytokines Stimulate CCL20 Expression in Keratinocytes In Vitro and In Vivo: Implications for Psoriasis PathogenesisJournal of Investigative Dermatology, 2009
- Increased frequencies of T helper type 17 cells in the peripheral blood of patients with acute myeloid leukaemiaClinical and Experimental Immunology, 2009
- Type 17 CD8+ T cells display enhanced antitumor immunityBlood, 2009
- Tumor-specific Th17-polarized cells eradicate large established melanomaBlood, 2008
- Phenotypic Analysis of Prostate-Infiltrating Lymphocytes Reveals TH17 and Treg SkewingClinical Cancer Research, 2008
- Photodynamic therapy and anti-tumour immunityNature Reviews Cancer, 2006